title: Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men.
abstract: The aim of this study was to evaluate the effect of selective and short-term sex hormone modifications on ghrelin levels in normal-weight eugonadal men undergoing hormonal contraceptive treatments. Seven men received an oral progestin [cyproterone acetate (CPA) or dienogest (DNG)] 10 mg/day for 3 weeks (CPA-DNG group), 7 CPA orally 5 mg/day in association with testosterone enanthate (TE) im 200 mg/week for 8 weeks (CPA-TE group), and 7 placebo (PLAC) for 8 weeks (PLAC group). Anthropometry and blood levels of LH, FSH, testosterone, estradiol, glucose, insulin and total ghrelin were evaluated. At baseline, no parameters differed among the three groups. After treatment, LH and FSH decreased in both CPA-DNG and CPA-TE groups, whereas they did not change in the PLAC group. Testosterone and estradiol decreased in the CPA-DNG group to the hypogonadal range, increased in the CPA-TE group to supraphysiological concentrations and, as expected, remained unchanged in the PLAC group. Total ghrelin levels increased in the CPA-DNG, decreased in the CPA-TE and did not change in the PLAC group. Ns modifications in the other parameters were observed in any group, demonstrating that the short-term changes of circulating sex hormones are able to modify ghrelin levels. These data, therefore, suggest that sex steroids are important regulators of ghrelin in normal-weight healthy men too.
authors.affiliation: Endocrinology Unit, Department of Internal Medicine, and Center for Applied Biomedical Research (C.R.B.A.), S. Orsola-Malpighi Hospital, Bologna, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Gambineri
authors.forename: U
authors.initials: U
authors.lastname: Pagotto
authors.forename: R
authors.initials: R
authors.lastname: De Lasio
authors.forename: M C
authors.initials: MC
authors.lastname: Meriggiola
authors.forename: A
authors.initials: A
authors.lastname: Costantino
authors.forename: L
authors.initials: L
authors.lastname: Patton
authors.forename: C
authors.initials: C
authors.lastname: Pelusi
authors.forename: G
authors.initials: G
authors.lastname: Pelusi
authors.forename: R
authors.initials: R
authors.lastname: Pasquali
mesh_terms: D000328:Adult; D000728:Androgens / Q000097:blood; D000886:Anthropometry; D001794:Blood Pressure / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D003272:Contraceptive Agents, Male / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000494:pharmacology; D017373:Cyproterone Acetate / Q000494:pharmacology; D004958:Estradiol / Q000097:blood; D054439:Ghrelin; D012739:Gonadal Steroid Hormones / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000494:pharmacology; D036361:Peptide Hormones / Q000097:blood*; D013739:Testosterone / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D000728:Androgens; D003272:Contraceptive Agents, Male; D003278:Contraceptives, Oral, Hormonal; D054439:Ghrelin; D012739:Gonadal Steroid Hormones; D036361:Peptide Hormones; D013739:Testosterone; C023635:dienogest; D017373:Cyproterone Acetate; D004958:Estradiol; D009277:Nandrolone; C004648:testosterone enanthate